Call for Abstract

10th World Congress on Pharmacology, will be organized around the theme “State-of-the-art Education on New Developments in Pharmacology”

Pharmacology 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pharmacology 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Pharmacology  is the study of how substances interact with living organisms to produce a change in function. It deals with the research, discovery, and characterization of chemicals which show biological effects and the illumination of cellular and organism function in relation to these chemicals. If substances have medicinal properties, they are considered pharmaceuticals. The Pharmacology encompasses mechanisms of drug action, drug composition and properties, interactions, toxicology, therapies, medical applications, and antipathogenic capabilities.

  • Track 1-1Scope
  • Track 1-2Medicine development and safety testing
  • Track 1-3Drug legislation and safety
  • Track 1-4Nutritional deficiency and disorders

Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of neuropharmacology: behavioral and molecular. Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of neuropharmacology: behavioral and molecular. It is dealt with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems.

The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.

  • Track 2-1Dose response relation in psychiatric medications
  • Track 2-2Neurogenesis and repair
  • Track 2-3Alzheimer’s and Parkinson’s disease
  • Track 2-4Neurochemical interactions
  • Track 2-5Molecular neuropharmacology
  • Track 2-6Behavioral neuropharmacology
  • Track 2-7Neuro Immune pharmacology and its associated diseases
  • Track 2-8Psychotherapy and innovative psychopharmacological approaches

Clinical Pharmacology has been practiced for centuries through observing the effects of herbal remedies and early drugs on humans. The pharmacologic effect that a medication has on the body is known as pharmacodynamics. Pharmacokinetic and pharmacodynamic parameters become important because of the association between host drug concentrations, microorganism eradication, and resistance. Since long scientific advances allowed scientists to come together with the study of physiological effects with biological effects Receptor theory for drug effects and its discovery with clinical pharmacology has stretched out to be a multidisciplinary field and has contributed to the findings of drug interaction, therapeutic effectiveness and safety. Drug interactions and pharmacological compatibilities include the study of pharmacokinetics that includes the absorption, distribution, metabolism, and elimination of drugs. The pharmacologic effect that a medication has on the body is known as pharmacodynamics. Pharmacokinetic and pharmacodynamic parameters become especially important because of the association between drug application, microorganism abolition, and resistance.

  • Track 3-1Drug development and interactions
  • Track 3-2Adverse Drug Effects
  • Track 3-3Receptor theory for drug effects
  • Track 3-4Pharmacokinetic and pharmacodynamic parameters

Pharmacokinetic and pharmacodynamic parameters become important because of the association between host drug concentrations, microorganism eradication, and resistance.Since long scientific advances allowed scientists to come together with the study of physiological effects with biological effects.

The Pharmaceutical industry's long successful strategy of placing big bets on a few molecules, promoting them heavily and turning them into blockbusters worked well for many years, but its R&D productivity has now plummeted and the environment’s changing.

  • Track 4-1Drug biotransformation reactions
  • Track 4-2Pharmacokinetic aspects
  • Track 4-3Drug interactions and pharmacological compatibilities
  • Track 4-4Receptor theory for drug effects
  • Track 4-5Clinical efficacy and safety evaluation
  • Track 4-6Novel options for the pharmacological treatment of chronic diseases

Pharmacology of vascular endothelium deals with alterations of endothelial cells and the vasculature play a central role in the pathogenesis of a broad spectrum of the most dreadful of human diseases, as endothelial cells have the key function of participating in the maintenance of patent and functional capillaries.

This market is expected to increase from nearly $17.1 billion in 2015 to $23 billion by 2020, with a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.

  • Track 5-1Pharmacology of drugs affecting vascular tone and blood pressure
  • Track 5-2Role of drugs in coronary circulation
  • Track 5-3Drugs and the electrical conduction of the heart
  • Track 5-4Drugs and the failing heart
  • Track 5-5Pharmacology of the Vascular endothelium

Ethnopharmacology is the branch of pharmacology that deals with the exchange of information and understandings about people's use of plants, fungi, animals, microorganisms and minerals and their biological and pharmacological effects based on the principles established through international conventions.

The pharmaceutical market been increasingly more affected through laws and regulations but has shown continuous growth as the diagnosis and understanding of diseases and condition has evolved and improved. BCC Research report’s cover the latest pharmaceutical market and provide in-depth market analysis, forecasts, trends, patent analysis, and profiles of major players within the markets.

  • Track 6-1Latest trends in ethnopharmacology
  • Track 6-2Integrative pharmacological investigations
  • Track 6-3Ethnopharmacological perspectives from traditional to modern pharmaceuticals
  • Track 6-4Natural products chemistry in drug discovery
  • Track 6-5Chemistry and structural elucidation
  • Track 6-6Natural and synthetic derivatives in pharmacological studies

Immunopharmacology is that area of pharmacological sciences dealing with the selective variation of specific immune responses and, in particular, of immune cell subsets. The first generation of immune-modulating agents included molecules drawn from oncology.  The second generation, notably cyclosporine, exploited some natural agents able to block several signal transduction pathways.

To deal with the expanding field of immunopharmacology, some limitations are required. However, in recent years, the advances about how the immune system works have identified several molecular targets suitable for more selective modulation of immune function. These targets can be broadly divided into surface molecules and soluble mediators. Surface molecules play a fundamental role in antigen recognition, immune response activation, homing and effector functions. Soluble mediators are involved in lymphocyte proliferation and differentiation, inflammatory response and cell recruitment.

  • Track 7-1Autoimmunity & autoimmune disorders
  • Track 7-2Immunotoxicology
  • Track 7-3Innate Immunity
  • Track 7-4Immunopathology
  • Track 7-5Immunotherapy

Pharmacogenetics refers to how variation in one single gene influences the response to a single drug and Pharmacogenomicsrefers to how all of the genes (the genome) can influence responses to drugs. The general feature of these diverse lesions is that two nucleotides on opposite strands are joined covalently. Mutagenicity and carcinogenicity are clearly correlated.Understanding the specificity of mutagens in bacteria has led to the direct implication of certain environmental mutagens in the causation of human cancers

The Pharmaceutical industry's long successful strategy of placing big bets on a few molecules, promoting them heavily and turning them into blockbusters worked well for many years, but its R&D productivity has now plummeted and the environment’s changing. Regulators are becoming more cautious about approving truly innovative medicines.

  • Track 8-1Molecular epidemiology and its biomarkers
  • Track 8-2Molecular pathological epidemiology
  • Track 8-3Pharmacovigilance and post marketing surveillance
  • Track 8-4Adverse event reporting system

Toxicology is the study of the undesirable effects of chemicals on living organisms. It is the study of symptoms, mechanisms, treatments and detection of poisoning, especially the poisoning of people.

The global market for selected healthcare-acquired infection (HAI) treatments was valued at nearly $15.2 billion in 2014. This market is expected to increase from nearly $17.1 billion in 2015 to $23 billion by 2020, with a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.

  • Track 9-1Dose response complexities
  • Track 9-2Computational toxicology
  • Track 9-3Clinical toxinology
  • Track 9-4Toxins and toxinology

Reverse pharmacology includes drug screening deals with reverse pharmacology and forward pharmacology are two approaches to drug discovery. Target based drug discovery is the process through which potential new medicines are identified.

The global market for drug discovery technologies reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019.

  • Track 10-1Reverse pharmacology
  • Track 10-2Target based drug discovery
  • Track 10-3Screening of chemical libraries and its pharmacology
  • Track 10-4Methods To determine biological targeting
  • Track 10-5Classical pharmacology

Liposomes and nanoparticles: Nanoscale drug delivery systems using liposomes and nanoparticles are rising technologies for the rational delivery of chemotherapeutic drugs in the treatment various ailments. Nanoparticles present possible dangers, both medically and environmentally.

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.

  • Track 11-1Liposomes and nanoparticles: Nanosized vehicles for drug delivery
  • Track 11-2Epigenetic mechanisms of importance for drug treatment
  • Track 11-3Pharmacometrics
  • Track 11-4Techniques: The application of accelerator mass spectrometry to pharmacology and toxicology

Ocular Pharmacology deals with basic and clinical research about biopharmaceuticals that have the potential to prevent, treat, and/or diagnose ocular diseases and disorders and its associated treatments. Ophthalmic diseases include those both analogous to systemic diseases (e.g., inflammation, infection, neuronal degeneration) and not analogous (e.g., cataract, myopia). Many anterior segment diseases are treated pharmacologically through eye drops, which have an implied therapeutic index of local therapy. Unlike administering pills for systemic diseases, eyedrops require patients not only to adhere to treatment, but to be able to accurately perform - i.e., instill drops correctly

The global market for selected healthcare-acquired infection (HAI) treatments was valued at nearly $15.2 billion in 2014. This market is expected to increase from nearly $17.1 billion in 2015 to $23 billion by 2020, with a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.

  • Track 12-1Glaucoma and its advanced and intregrated treatments
  • Track 12-2Ocular pharmacotherapy/clinical trials
  • Track 12-3Ocular drug delivery and biotransformation
  • Track 12-4Ocular ischemia and blood flow
  • Track 12-5Ocular inflammatory and immune disorders

Biochemical pharmacology is based on principles of drug action. Biochemical pharmacology uses the methods of biochemistry, biophysics, molecular biology, structural biology, cell biology, and cell physiology to define the mechanisms of drug action and how drugs influence the organism by studies on intact animals, organs, cells, subcellular compartments and individual protein molecules.

An overview of biopharmaceutical single-use technologies, which aid the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters. Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.

  • Track 13-1Use of tissue and animal models of human pathophysiology and toxicology
  • Track 13-2Mechanism of drug action, safety and efficacy
  • Track 13-3Mechanisms of drug absorption across membranes
  • Track 13-4Drug biotransformation reactions

Recent advances in DNA repair are DNA interstrand cross-links (ICLs) are lesions caused by a variety of endogenous metabolites, ecological exposures, and cancer chemotherapeutic agents that have two reactive groups.

An overview of biopharmaceutical single-use technologies, which aid the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters. Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.

  • Track 14-1Molecular epidemiology and its biomarkers
  • Track 14-2Molecular pathological epidemiology
  • Track 14-3Pharmacovigilance and post marketing surveillance
  • Track 14-4Adverse event reporting system

Development of medication is a vital concern to medicine. The metabolic stability and the reactivity of a library of candidate drug compounds have to be assessed for drug metabolism and toxicological studies. Many methods of pharmacological tests have been proposed for quantitative predictions in drug metabolism.

The pharmaceutical market been increasingly more affected through laws and regulations but has shown continuous growth as the diagnosis and understanding of diseases and condition has evolved and improved. BCC Research report’s cover the latest pharmaceutical market and provide in-depth market analysis, forecasts, trends, patent analysis, and profiles of major players within the markets. Comprehensive analysis of clinical studies for biopharmaceuticals, prevention and treatment of certain cancers, coagulants and non-coagulants are all within the range of pharmaceutical markets covered in BCC Research reports. Drug devices, instrumentation and inhibitors are some of the many other areas covered.

  • Track 15-1Advances in stress test
  • Track 15-2Advances in nuclear stress test
  • Track 15-3Advances in pharmacological testing
  • Track 15-4Safety pharmacology

Pharmacology for nurses is one of the most important elements in nursing education. It is the field is science that is related to management of drugs as per the disease profile of the patient. This i sa special track designed in Pharmacology 2016 Conference.

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.

  • Track 16-1Clinical nursing
  • Track 16-2Nursing Implications
  • Track 16-3Women and cardiac diseases
  • Track 16-4Health promotion/Disease prevention